理想汽車(02015.HK)上月理想ONE交付量按年增長190.2%
理想汽車(02015.HK)(LI.US)公佈,於11月交付1.35萬輛理想ONE,按年增長190.2%。今年首十一個月,理想ONE總交付量達7.6萬輛。自交付以來,理想ONE累計交付量已達11萬輛。
公司聯合創始人兼總裁沈亞楠表示,理想ONE在11月創造了單月交付超過1.3萬輛的新紀錄,也是起售價超過30萬元人民幣的中國品牌豪華車型第一次實現單月交付破萬,成爲中國中大型SUV和家庭用戶的首選產品之一。
截至11月底,公司在全國已有174家零售中心,覆蓋93個城市;售後維修中心及理想汽車授權鈑噴中心236家,覆蓋171個城市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.